Skip to main content

Abstract

This chapter will discuss the role of chemistry within the pharmaceutical industry. Although the focus will be upon the industry within the United States, much of the discussion is equally relevant to pharmaceutical companies based in other first world nations such as Japan and those in Europe. The major objective of the pharmaceutical industry is the discovery, development, and marketing of efficacious and safe drugs for the treatment of human disease. Of course drug companies do not exist as altruistic, charitable organizations but like other share-holder owned corporations within our capitalistic society must achieve profits in order to remain viable and competitive. Thus, there exists a conundrum between the dual goals of enhancing the quality and duration of human life and that of increasing stock-holder equity. Much has been written and spoken in the lay media about the high prices of prescription drugs and the hardships this places upon the elderly and others of limited income.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 249.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Krogsgaard-Larsen, P., Liljefors, T., and Madsen, U. (Eds.), A Textbook of Drug Design and Development, 2nd. ed., Harwood Academic Publishers, Amsterdam, (1996).

    Google Scholar 

  2. Spilker, B., Multinational Drug Companies; Issues in Drug Discovery and Development, Raven Press, New York, (1989).

    Google Scholar 

  3. Wermuth, C.G. (Ed.), The Practice of Medicinal Chemistry, Academic Press, San Diego, (1996).

    Google Scholar 

  4. Lipinski, C.A., Lombardo, F., Dominy, D.W., and Feeny, P. J., Adv. Drug Delivery Rev., 23, 3–25 (1997).

    Article  CAS  Google Scholar 

  5. Testa, B., and Mayer, J. M., Drug Metab Rev., 30, 787–807 (1998).

    Article  CAS  Google Scholar 

  6. Wess, G., Urmann, M., and Sickenberger, B., Angew. Chem. Int. Ed., 40, 3341–3350 (2001).

    Article  CAS  Google Scholar 

  7. Miertus, S., and Fassina, G. (Eds.), Combinatorial Chemistry and Technology; Principles, Methods and Applications, Marcel Dekker, Inc., New York, (1999).

    Google Scholar 

  8. Dolle, R., J. Combinatorial Chem., 3, 477–518 (2001).

    Article  CAS  Google Scholar 

  9. Anderson, N.G., Practical Process Research and Development, Academic Press, New York, (2000).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

James A. Kent Ph.D. (Professor of Chemical Engineering and Dean of Engineering)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Poindexter, G.S., Pendri, Y., Snyder, L.B., Yevich, J.P., Deshpande, M. (2007). Chemistry in the Pharmaceutical Industry. In: Kent, J.A. (eds) Kent and Riegel’s Handbook of Industrial Chemistry and Biotechnology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-27843-8_11

Download citation

Publish with us

Policies and ethics